DuPont reported robust third-quarter results, with net sales increasing by 6% year-over-year and operating EBITDA growing to $840 million, leading to an upward revision of full-year earnings guidance.

• Net sales reached $3.1 billion, driven by strong organic growth across all business segments, particularly in healthcare and electronics.
• Operating EBITDA margin improved to 27.3%, reflecting effective operational management and cost controls.
• The Board authorized a $2 billion share repurchase program and declared an initial quarterly dividend of $0.20 per share, emphasizing a commitment to shareholder value.
• The successful separation of Qnity positions DuPont to capitalize on semiconductor market opportunities and strengthen its pure-play technology offerings.
• Continued emphasis on innovation was highlighted with the launch of new technologies in personal protective equipment, reinforcing DuPont's market leadership.